Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01409317

Neural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major Depression

Neural Predictors and Longitudinal Neural Correlates of Clinical Improvement After Standard or Deep Transcranial Magnetic Stimulation in Major Depression: A Randomized Study

Sponsor: Brainsway

Conditions Major Depressive Disorder

Interventions Deep Transcranial Magnetic Stimulation Repetitive Transcranial Magnetic Stimulation

Updated 5 times since 2017 Last updated: May 26, 2015 Started: Apr 30, 2013 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Major Depressive Disorder, this trial is completed. The trial is conducted by Brainsway and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brainsway
Douglas Mental Health University Institute

Data source: Douglas Mental Health University Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada